Trial intelligence / Profile preview

@home study of Lybrido and Lybridos in women with female sexual dysfunction using SSRIs

NL-OMON23989Recruiting

Sponsor
Emotional Brain
Start
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of sildenafil + testosterone and Lybridos in female sexual dysfunction (FSD), hypoactive sexual desire disorder (HSDD), Sexual Arousal Disorder and 1 more (3 arms), sponsored by Emotional Brain. Primary endpoint: Primary efficacy endpoint. Started Jan 2010; status: recruiting.

02

Drugs

sildenafil + testosteroneLybridos
03

Conditions

female sexual dysfunction (FSD)hypoactive sexual desire disorder (HSDD)Sexual Arousal DisorderSSRI-induced sexual dysfunction

Beyond the preview

Go deeper on NL-OMON23989.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON23989.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call